Cargando…
Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance
The most promising method for monitoring patients with minimal morbidity is the detection of circulating melanoma cells (CMCs). We have shown that CD45(−)CD146(+)ABCB5(+) CMCs identify a rare primitive stem/mesenchymal CMCs population associated with disease progression. The epithelial-to-mesenchyma...
Autores principales: | Rapanotti, Maria Cristina, Cugini, Elisa, Campione, Elena, Di Raimondo, Cosimo, Costanza, Gaetana, Rossi, Piero, Ferlosio, Amedeo, Bernardini, Sergio, Orlandi, Augusto, De Luca, Anastasia, Bianchi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380315/ https://www.ncbi.nlm.nih.gov/pubmed/37511550 http://dx.doi.org/10.3390/ijms241411792 |
Ejemplares similares
-
Stem–Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients
por: Rapanotti, Maria Cristina, et al.
Publicado: (2020) -
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy
por: Rapanotti, Maria Cristina, et al.
Publicado: (2021) -
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146
por: Rapanotti, Maria Cristina, et al.
Publicado: (2017) -
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma
por: Rapanotti, Maria Cristina, et al.
Publicado: (2014) -
Bednar Tumour Occurring after Malignant Melanoma Excision
por: Ferlosio, Amedeo, et al.
Publicado: (2018)